Acute Acalculous Cholecystitis as a Presenting Manifestation in Systemic Lupus Erythematosus by Mohapatra, Sonmoon et al.
European Journal
of Case Reports in
Internal Medicine
DOI: 10.12890/2016_000408 European Journal of Case Reports in Internal Medicine © EFIM 2016
Doi: 10.12890/2016_000408 - European Journal of Case Reports in Internal Medicine - © EFIM 2016
Acute Acalculous Cholecystitis as a Presenting
 Manifestation in Systemic Lupus Erythematosus
Sonmoon Mohapatra1, Debra R Goldstein2, Akshat Kumar1, Trisha Saha1, Damodar Penigalapati1
1Department of Internal Medicine, Rutgers Robert Wood Johnson Medical School /Saint Peter’s University Hospital, New Brunswick, New Jersey, USA
2 Department of Gastroenterology and Hepatology, Rutgers Robert Wood Johnson Medical School/Saint Peter’s University Hospital, New Brunswick, 
New Jersey, USA
Received: 18/02/2016
Accepted: 22/03/2016
Published: 11/05/2016
How to cite this article: Mohapatra S, Goldstein DR, Kumar A, Saha T, Penigalapati D. Acute acalculous cholecystitis as a presenting manifestation in 
systemic lupus erytematosus. EJCRIM 2016;3:doi:10.12890/2016_000408.
Conflicts of Interests: The Authors declare that there are no competing interests.
This article is licensed under a Commons Attribution Non-Commercial 4.0 License
ABSTRACT
Systemic lupus erythematosus (SLE) is known to involve the gastrointestinal tract, but gallbladder involvement is rare. The authors report 
the case of a 26-year-old postpartum female who presented with acute right upper quadrant abdominal pain and was diagnosed with acute 
acalculous cholecystitis (AAC). In the presence of concomitant features of nephritis, pericardial effusion, anaemia and positive ANA titre, 
the diagnosis of SLE was confirmed during hospitalisation. Histopathological analysis of the gall bladder revealed evidence of vasculitis. 
Although rare, AAC can be the first presentation of patients diagnosed with SLE. Prompt diagnosis and management results in a better 
patient outcome.
LEARNING POINTS
• Although rare, acute acalculous cholecystitis is to be suspected in patients in the setting of right upper quadrant pain associated with 
multisystem disease as it may manifest as an initial symptom of the multisystem disease.
• In women with pre-existing rheumatological disease, a high index of suspicion for manifestations of postpartum flares should be 
maintained.
• Definitive treatment includes cholecystectomy; high-dose steroid therapy has been reported to be successful in a few cases.
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INTRODUCTION
Systemic lupus erythematosus (SLE) is a systemic autoimmune inflammatory disease with a wide spectrum of clinical manifestations. SLE 
seldom presents as acute acalculous cholecystitis (AAC). Initial presentation of SLE as AAC is also rare: only four cases have been reported 
in the literature[1,2]. This is the first reported case of SLE manifested as AAC during the postpartum period.
CASE REPORT
A 26-year-old Caucasian female presented with acute right upper quadrant (RUQ) pain. Two weeks previously she had had a caesarean 
section performed emergently at 28 weeks for what was thought to be severe pre-eclampsia. At the time of presentation, her vital signs were 
temperature 98.4°F, BP 119/81 mmHg, HR 104/min, RR 20/min, and O
2 
saturation 100% on 2 L nasal cannula. Physical examination showed 
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pallor, decreased breath sounds at the lung bases, RUQ tenderness with positive Murphy’s sign and bilateral pedal oedema. Laboratory 
studies showed WBC 20.8/mm3, haemoglobin 9 g/dl, platelet 271,000/mm3, BUN 75, creatinine 3.39 mg/dl, sodium 135 mEq/dl, potassium 
5.1 mEq/dl, chloride 105 mEq/dl, bicarbonate 18 mEq/dl, total bilirubin 0.6 mg/dl, AST 38 IU/l, ALT 25 IU/l, alkaline phosphatase 161 IU/l and 
ESR 97 mm/hr. Amylase and lipase level were normal. Urine analysis was positive for haematuria and 3+ proteinuria. Abdominal ultrasound 
showed gallbladder wall thickening and a normal sized common bile duct without evidence of stones. A clinical diagnosis of acute cholecystitis 
was made. Hepatobiliary iminodiacetic acid (HIDA) scan was unremarkable. The patient was empirically started on antibiotics. During 
hospitalization the RUQ pain worsened and the patient developed associated nausea, vomiting and fever. In the setting of the persistent 
RUQ pain and positive Murphy’s sign, a cholecystectomy was performed. Histology of the gallbladder specimen revealed focal areas of 
acute inflammation and fibrinoid changes suggestive of small vessel vasculitis (Fig. 1). Given the patient’s complex clinical presentation and 
multi-organ involvement, the diagnosis of SLE was considered. Immunological testing showed positive ANA (speckled pattern 1:1280), C3 
80 mg/dl, and C4 <8 mg/dl. Anti-dsDNA, lupus anticoagulant, anti-Smith antibody and anti-B2-glycoprotein antibody were all negative. The 
renal biopsy (Fig.1) showed diffuse endocapillary proliferative glomerulonephritis, immune complex type, suggestive of lupus nephritis (ISN-
RPS class IV-G). The patient’s condition markedly improved after surgery and she was discharged with oral prednisone and mycophenolate.
Figure 1 (A,B). Microscopic appearance of the gallbladder showing acute arteritis 
with fibrinoid changes and degeneration of the media of the arteries. 
(C,D): Immunofluorescence finding of diffuse granular mesangial and glomerular 
capillary wall staining for IgG, IgM and C3, supporting the diagnosis of an 
immune-complex mediated glomerulonephritis such as lupus nephritis.
DISCUSSION
Gastrointestinal (GI) manifestations of SLE include mouth ulcers, dysphagia, anorexia, nausea, vomiting, haemorrhage and abdominal 
pain. Symptoms can develop either from autoimmune tissue injury, complications of lupus-related organ dysfunction, thromboembolic 
manifestations of anti-phospholipid antibody syndrome, infection, medication and unrelated disorders. While the most common GI 
manifestations of SLE are seen in the oral cavity, GI vasculitis may potentially contribute to greater morbidity and mortality. Early recognition 
and treatment is important to optimize long-term survival. 
GI manifestations of lupus vasculitis are abdominal pain, nausea and vomiting. Although non-specific, these are usually accompanied by 
evidence of active disease elsewhere affecting the skin, renal and cardiovascular systems. The classic histological feature of cholecystitis 
in SLE is vasculitis of small vessel arteries and venules. Associated findings may include atrophy and degeneration of the media of small 
arteries, fibrinoid necrosis of the vessel walls, old thrombosis, phlebitis and monocyte infiltrate in the lamina propria[2]. Although vasculitis 
is a common complication of SLE, manifesting in up to 18% of patients, it is usually a cutaneous disease[3]. In this case, it was concluded that 
the cholecystitis was the result of vasculitis due to SLE. 
Helpful diagnostic parameters include complete blood count, liver and renal function tests, lactate, ANA, anti-dsDNA, C-reactive protein, 
blood sedimentation, C3 and C4 complement levels and antiphospholipid antibody status. Abdominal ultrasound, hepatobiliary scintigraphy 
and CT scan are indicated for the diagnosis. HIDA scan may be normal in ACC[4]. The most characteristic radiological findings, increased gall 
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bladder wall thickness and accumulated fluid in the gall bladder fossa in the absence of gallstones or sludge, were present in our imaging 
studies. 
AAC is known to have a high mortality rate. Definitive treatment includes cholecystectomy. In patients who are poor surgical candidates, 
cholecystostomy remains another option. Endoscopic therapy with nasobiliary drainage is a third option for patients who cannot tolerate 
either surgery or cholecystostomy[5]. High-dose steroid therapy has been reported to be successful in a few cases and can be tried in selected 
patients, depending on general condition, disease severity and associated risk factors[1, 2].
This case posed a diagnostic challenge. The patient symptoms satisfied the American College of Rheumatology (ACR) classification criteria 
of SLE. She had abdominal pain as well as renal failure and pericardial effusion. Anti-dsDNA antibody was negative despite the presence 
of active disease. SLE is well known for its atypical presentations, and this patient had a rare manifestation of SLE. As she had undergone 
caesarean section for suspected pre-eclampsia 2 weeks previously, we suspected acute cholecystitis secondary to gallstone disease. On 
further evaluation, however, the patient was found to have AAC secondary to SLE, which itself is often seen to flare in the immediate 
postpartum period. 
Our patient, managed promptly, markedly improved after surgery. Our case is the first reported case of SLE manifested as AAC during the 
postpartum period. Although rare, we want to emphasize that AAC can present as an initial manifestation of SLE. Prompt diagnosis and 
management is required for better patient outcome. 
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